Fabry Disease Patient Recruitment in Connecticut

TheraNovex connects clinical trial sponsors with pre-screened, eligible Fabry Disease patients across Connecticut, including Bridgeport, New Haven, Hartford, and beyond.

Fabry disease patient recruitment for ERT, chaperone therapy, and substrate reduction clinical trials.

Who qualifies: Males and females with confirmed Fabry disease (GLA mutation) with or without prior ERT.

Recruitment challenges: GLA mutation confirmation and alpha-galactosidase A enzyme activity requirements.

Our approach: Metabolic disease center networks, Fabry patient registry access, and enzyme activity pre-screening.

Our recruitment network spans all major metropolitan areas in Connecticut, ensuring broad geographic coverage for your Fabry Disease trial.